Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

Bibliography

• 1  Moss B: Poxviridae: The Viruses and Their Replication. Lippincott Williams and Wilkins, PA, USA.
  Google Scholar
• 2  Carroll MW, Moss B: Poxviruses as expression vectors. Curr. Opin. Biotechnol.8,573–577 (1997).
  Medline CASGoogle Scholar
• 3  Drexler I, Heller K, Wahren B, Erfle V, Sutter G: Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells. J. Gen. Virol.79(Pt 2),347–352 (1998).
  Medline CASGoogle Scholar
• 4  Payne LG: Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia. J. Gen. Virol.50,89–100 (1980).
  Medline CASGoogle Scholar
• 5  Tscharke DC, Reading PC, Smith GL: Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes. J. Gen. Virol.83,1977–1986 (2002).
  Medline CASGoogle Scholar
• 6  Lane JM, Ruben FL, Neff JM, Millar JD: Complications of smallpox vaccination, 1968. N. Engl. J. Med.281,1201–1208 (1969).
  Medline CASGoogle Scholar
• 7  Wollenberg A, Engler R: Smallpox, vaccination and adverse reactions to smallpox vaccine. Curr. Opin. Allergy Clin. Immunol.4,271–275 (2004).
  MedlineGoogle Scholar
• 8  Goebel SJ, Johnson GP, Perkus ME, Davis SW, Winslow JP, Paoletti E: The complete DNA sequence of vaccinia virus. Virology179,247–266 (1990).
  Medline CASGoogle Scholar
• 9  Assarsson E, Greenbaum JA, Sundstrom M et al.: Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes. Proc. Natl Acad. Sci. USA105,2140–2145 (2008).▪▪ First complete experimental map of vaccinia virus mRNA expression.
  Medline CASGoogle Scholar
• 10  Amara RR, Nigam P, Sharma S, Liu J, Bostik V: Long-lived poxvirus immunity, robust CD4 help, and better persistence of CD4 than CD8 T cells. J. Virol.78,3811–3816 (2004).
  Medline CASGoogle Scholar
• 11  Crotty S, Felgner P, Davies H, Glidewell J, Villarreal L, Ahmed R: Cutting edge: long-term B cell memory in humans after smallpox vaccination. J. Immunol.171,4969–4973 (2003).
  Medline CASGoogle Scholar
• 12  Demkowicz WE, Littaua RA Jr, Wang J, Ennis FA: Human cytotoxic T-cell memory: long-lived responses to vaccinia virus. J. Virol.70,2627–2631 (1996).
  Medline CASGoogle Scholar
• 13  el-Ad B, Roth Y, Winder A et al.: The persistence of neutralizing antibodies after revaccination against smallpox. J. Infect. Dis.161,446–448 (1990).
  Medline CASGoogle Scholar
• 14  Hammarlund E, Lewis MW, Hansen SG et al.: Duration of antiviral immunity after smallpox vaccination. Nat. Med.9,1131–1137 (2003).
  Medline CASGoogle Scholar
• 15  Putz MM, Alberini I, Midgley CM, Manini I, Montomoli E, Smith GL: Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy. J. Gen. Virol.86,2955–2960 (2006).
  Google Scholar
• 16  Fang M, Sigal LJ: Antibodies and CD8⁺ T cells are complementary and essential for natural resistance to a highly lethal cytopathic virus. J. Immunol.175,6829–6836 (2005).
  Medline CASGoogle Scholar
• 17  Panchanathan V, Chaudhri G, Karupiah G: Correlates of protective immunity in poxvirus infection: where does antibody stand? Immunol. Cell. Biol.86,80–86 (2008).
  Medline CASGoogle Scholar
• 18  Evans E, Traktman P: Molecular genetic analysis of a vaccinia virus gene with an essential role in DNA replication. J. Virol.61,3152–3162 (1987).
  Medline CASGoogle Scholar
• 19  Garces J, Masternak K, Kunz B, Wittek R: Reactivation of transcription from a vaccinia virus early promoter late in infection. J. Virol.67,5394–5401 (1993).
  Medline CASGoogle Scholar
• 20  McDonald WF, Crozel-Goudot V, Traktman P: Transient expression of the vaccinia virus DNA polymerase is an intrinsic feature of the early phase of infection and is unlinked to DNA replication and late gene expression. J. Virol.66,534–547 (1992).
  Medline CASGoogle Scholar
• 21  Schmitt JF, Stunnenberg HG: Sequence and transcriptional analysis of the vaccinia virus HindIII I fragment. J. Virol.62,1889–1897 (1988).
  Medline CASGoogle Scholar
• 22  Vos JC, Stunnenberg HG: Derepression of a novel class of vaccinia virus genes upon DNA replication. EMBO J.7,3487–3492 (1988).
  Medline CASGoogle Scholar
• 23  Lee-Chen GJ, Bourgeois N, Davidson K, Condit RC, Niles EG: Structure of the transcription initiation and termination sequences of seven early genes in the vaccinia virus HindIII D fragment. Virology163,64–79 (1988).
  Medline CASGoogle Scholar
• 24  Roseman NA, Hruby DE: Nucleotide sequence and transcript organization of a region of the vaccinia virus genome which encodes a constitutively expressed gene required for DNA replication. J. Virol.61,1398–1406 (1987).
  Medline CASGoogle Scholar
• 25  Grosenbach DW, Hansen SG, Hruby DE: Identification and analysis of vaccinia virus palmitylproteins. Virology275,193–206 (2000).
  Medline CASGoogle Scholar
• 26  Parkinson JE, Smith GL: Vaccinia virus gene A36R encodes a M(r) 43–50 K protein on the surface of extracellular enveloped virus. Virology204,376–390 (1994).
  Medline CASGoogle Scholar
• 27  Tolonen N, Doglio L, Schleich S, Krijnse Locker J: Vaccinia virus DNA replication occurs in endoplasmic reticulum-enclosed cytoplasmic mini-nuclei. Mol. Biol. Cell12,2031–2046 (2001).
  Medline CASGoogle Scholar
• 28  Gardner JD, Tscharke DC, Reading PC, Smith GL: Vaccinia virus semaphorin A39R is a 50–55 kDa secreted glycoprotein that affects the outcome of infection in a murine intradermal model. J. Gen. Virol.82,2083–2093 (2001).
  Medline CASGoogle Scholar
• 29  Norbury CC, Basta S, Donohue KB et al.: CD8⁺ T cell cross-priming via transfer of proteasome substrates. Science304,1318–1321 (2004).
  Medline CASGoogle Scholar
• 30  Yeh WW, Moss B, Wolffe EJ: The vaccinia virus A9L gene encodes a membrane protein required for an early step in virion morphogenesis. J. Virol.74,9701–9711 (2000).
  Medline CASGoogle Scholar
• 31  Chung CS, Chen CH, Ho MY, Huang CY, Liao CL, Chang W: Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles. J. Virol.80,2127–2140 (2006).▪▪ Provides key data in terms of the expression of different proteins in vaccinia virus.
  Medline CASGoogle Scholar
• 32  Resch W, Hixson KK, Moore RJ, Lipton MS, Moss B: Protein composition of the vaccinia virus mature virion. Virology358,233–247 (2007).▪▪ Provides key data in terms of the expression of different proteins in vaccinia virus.
  Medline CASGoogle Scholar
• 33  Yoder JD, Chen TS, Gagnier CR, Vemulapalli S, Maier CS, Hruby DE: Pox proteomics: mass spectrometry analysis and identification of vaccinia virion proteins. Virol. J.3,10 (2006).▪▪ Provides key data in terms of the expression of different proteins in vaccinia virus.
  MedlineGoogle Scholar
• 34  Gygi SP, Rochon Y, Franza BR, Aebersold R: Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol.19,1720–1730 (1999).
  Medline CASGoogle Scholar
• 35  Aldaz-Carroll L, Whitbeck JC, Ponce de Leon M et al.: Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R. J. Virol.79,6260–6271 (2005).
  Medline CASGoogle Scholar
• 36  Aldaz-Carroll L, Whitbeck JC, Ponce de Leon M et al.: Physical and immunological characterization of a recombinant secreted form of the membrane protein encoded by the vaccinia virus L1R gene. Virology341,59–71 (2005).
  Medline CASGoogle Scholar
• 37  Assarsson E, Sidney J, Oseroff C et al.: A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infection. J. Immunol.178,7890–7901 (2007).
  Medline CASGoogle Scholar
• 38  Bell E, Shamim M, Whitbeck JC, Sfyroera G, Lambris JD, Isaacs SN: Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin. Virology325,425–431 (2004).
  Medline CASGoogle Scholar
• 39  Benhnia MR, McCausland MM, Su HP et al.: Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine. J. Virol.82,3751–3768 (2008).
  Medline CASGoogle Scholar
• 40  Calvo-Calle JM, Strug I, Nastke MD, Baker SP, Stern LJ: Human CD4⁺ T cell epitopes from vaccinia virus induced by vaccination or infection. PLoS Pathog.3,1511–1529 (2007).▪ Early study mapping CD4 responses in humans.
  Medline CASGoogle Scholar
• 41  Cornberg M, Sheridan BS, Saccoccio FM, Brehm MA, Selin LK: Protection against vaccinia virus challenge by CD8 memory T cells resolved by molecular mimicry. J. Virol.81,934–944 (2007).
  Medline CASGoogle Scholar
• 42  Davies DH, Liang X, Hernandez JE et al.: Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc. Natl Acad. Sci. USA102,547–552 (2005).▪ Key study mapping antibody responses to vaccinia.
  Medline CASGoogle Scholar
• 43  Davies DH, McCausland MM, Valdez C et al.: Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice. J. Virol.79,11724–11733 (2005).
  Medline CASGoogle Scholar
• 44  Davies DH, Molina DM, Wrammert J et al.: Proteome-wide analysis of the serological response to vaccinia and smallpox. Proteomics7,1678–1686 (2007).▪ Key study mapping antibody responses to vaccinia.
  Medline CASGoogle Scholar
• 45  Davies DH, Wyatt LS, Newman FK et al.: Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax. J. Virol.82,652–663 (2008).
  Medline CASGoogle Scholar
• 46  Dong Y, Denny TN: HLA-A2-restricted human CD8(⁺) cytotoxic T lymphocyte responses to a novel epitope in vaccinia virus that is conserved among orthopox viruses. J. Infect. Dis.194,168–175 (2006).
  Medline CASGoogle Scholar
• 47  Drexler I, Staib C, Kastenmuller W et al.: Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines. Proc. Natl Acad. Sci. USA100,217–222 (2003).▪▪ Early study mapping CD8 responses in humans.
  Medline CASGoogle Scholar
• 48  Golden JW, Hooper JW: Heterogeneity in the A33 protein impacts the cross-protective efficacy of a candidate smallpox DNA vaccine. Virology377,19–29 (2008).
  Medline CASGoogle Scholar
• 49  Jing L, Chong TM, Byrd B et al.: Dominance and diversity in the primary human CD4 T cell response to replication-competent vaccinia virus. J. Immunol.178,6374–6386 (2007).▪▪ Early study mapping CD4 responses in humans.
  Medline CASGoogle Scholar
• 50  Jing L, Chong TM, McClurkan CL, Huang J, Story BT, Koelle DM: Diversity in the acute CD8 T cell response to vaccinia virus in humans. J. Immunol.175,7550–7559 (2005).
  Medline CASGoogle Scholar
• 51  Jing L, Davies DH, Chong TM et al.: An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T-cell profiling. J. Virol.82,7120–7134 (2008).
  Medline CASGoogle Scholar
• 52  Johnson KL, Ovsyannikova IG, Madden BJ, Poland GA, Muddiman DC: Accurate mass precursor ion data and tandem mass spectrometry identify a class I human leukocyte antigen A*0201-presented peptide originating from vaccinia virus. J. Am. Soc. Mass. Spectrom.16,1812–1817 (2005).
  Medline CASGoogle Scholar
• 53  Mathew A, Terajima M, West K et al.: Identification of murine poxvirus-specific CD8⁺ CTL epitopes with distinct functional profiles. J. Immunol.17,2212–2219 (2005).
  Google Scholar
• 54  Meyer VS, Kastenmuller W, Gasteiger G et al.: Long-term immunity against actual poxviral HLA ligands as identified by differential stable isotope labeling. J. Immunol.181,6371–6383 (2008).
  Medline CASGoogle Scholar
• 55  Midgley CM, Putz MM, Weber JN, Smith GL: Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax. J. Gen. Virol.89,2992–2997 (2008).
  Medline CASGoogle Scholar
• 56  Mitra-Kaushik S, Cruz J, Stern LJ, Ennis FA, Terajima M: Human cytotoxic CD4⁺ T cells recognize HLA-DR1-restricted epitopes on vaccinia virus proteins A24R and D1R conserved among poxviruses. J. Immunol.179,1303–1312 (2007).
  Medline CASGoogle Scholar
• 57  Moutaftsi M, Bui HH, Peters B et al.: Vaccinia virus-specific CD4⁺ T cell responses target a set of antigens largely distinct from those targeted by CD8⁺ T cell responses. J. Immunol.178,6814–6820 (2007).▪▪ Identification of murine CD4 responses and comparison with CD8 responses.
  Medline CASGoogle Scholar
• 58  Moutaftsi M, Peters B, Pasquetto V et al.: A consensus epitope prediction approach identifies the breadth of murine T(CD8⁺)-cell responses to vaccinia virus. Nat. Biotechnol.24,817–819 (2006).▪▪ Complete profiling of CD8 responses against vaccinia in mice.
  Medline CASGoogle Scholar
• 59  Oseroff C, Kos F, Bui HH et al.: HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation. Proc. Natl Acad. Sci. USA102,13980–13985 (2005).▪▪ Early study mapping CD8 responses in humans.
  Medline CASGoogle Scholar
• 60  Oseroff C, Peters B, Pasquetto V et al.: Dissociation between epitope hierarchy and immunoprevalence in CD8 responses to vaccinia virus western reserve. J. Immunol.180,7193–7202 (2008).
  Medline CASGoogle Scholar
• 61  Ostrout ND, McHugh MM, Tisch DJ, Moormann AM, Brusic V, Kazura JW: Long-term T cell memory to human leucocyte antigen-A2 supertype epitopes in humans vaccinated against smallpox. Clin. Exp. Immunol.149,265–273 (2007).
  Medline CASGoogle Scholar
• 62  Pasquetto V, Bui HH, Giannino R et al.: HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products. J. Immunol.175,5504–5515 (2005).
  Medline CASGoogle Scholar
• 63  Putz MM, Midgley CM, Law M, Smith GL: Quantification of antibody responses against multiple antigens of the two infectious forms of vaccinia virus provides a benchmark for smallpox vaccination. Nat. Med.12,1310–1315 (2006).
  MedlineGoogle Scholar
• 64  Sahin U, Tureci O, Graf C et al.: Rapid molecular dissection of viral and bacterial immunomes. Eur J. Immunol.36,1049–1057 (2006).
  Medline CASGoogle Scholar
• 65  Sette A, Moutaftsi M, Moyron-Quiroz J et al.: Selective CD4⁺ T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities. Immunity28,847–858 (2008).▪▪ Key study establishing a link between the specificities recognized by CD4 and antibody responses.
  Medline CASGoogle Scholar
• 66  Smith CL, Mirza F, Pasquetto V et al.: Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara. J. Immunol.175,8431–8437 (2005).
  Medline CASGoogle Scholar
• 67  Snyder JT, Belyakov IM, Dzutsev A, Lemonnier F, Berzofsky JA: Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8⁺ T-cell peptide epitope of vaccinia and variola viruses. J. Virol.78,7052–7060 (2004).▪▪ Early study probing the mechansism of protection.
  Medline CASGoogle Scholar
• 68  Strug I, Calvo-Calle JM, Green KM et al.: Vaccinia peptides eluted from HLA-DR1 isolated from virus-infected cells are recognized by CD4⁺ T cells from a vaccinated donor. J. Proteome Res.7,2703–2711 (2008).
  Medline CASGoogle Scholar
• 69  Su HP, Golden JW, Gittis AG, Hooper JW, Garboczi DN: Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 protein. Virology368,331–341 (2007).
  Medline CASGoogle Scholar
• 70  Tang J, Murtadha M, Schnell M, Eisenlohr LC, Hooper J, Flomenberg P: Human T-cell responses to vaccinia virus envelope proteins. J. Virol.80,10010–10020 (2006).
  Medline CASGoogle Scholar
• 71  Terajima M, Cruz J, Leporati AM, Demkowicz WE, Kennedy JS Jr, Ennis FA: Identification of vaccinia CD8⁺ T-cell epitopes conserved among vaccinia and variola viruses restricted by common MHC class I molecules, HLA-A2 or HLA-B7. Hum. Immunol.67,512–520 (2006).
  Medline CASGoogle Scholar
• 72  Terajima M, Cruz J, Raines G et al.: Quantitation of CD8⁺ T cell responses to newly identified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses. J. Exp. Med.197,927–932 (2003).▪▪ Early study mapping CD8 responses in humans.
  Medline CASGoogle Scholar
• 73  Terajima M, Orphin L, Leporati AM et al.: Vaccinia virus-specific CD8(⁺) T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humans. Hum. Immunol.69,815–825 (2008).
  Medline CASGoogle Scholar
• 74  Tscharke DC, Karupiah G, Zhou J et al.: Identification of poxvirus CD8⁺ T cell determinants to enable rational design and characterization of smallpox vaccines. J. Exp. Med.201,95–104 (2005).▪▪ Early study mapping CD8 responses in mice.
  Medline CASGoogle Scholar
• 75  Tscharke DC, Woo WP, Sakala IG et al.: Poxvirus CD8⁺ T-cell determinants and cross-reactivity in BALB/c mice. J. Virol.80,6318–6323 (2006).
  Medline CASGoogle Scholar
• 76  Weaver JR, Shamim M, Alexander E, Davies DH, Felgner PL, Isaacs SN: The identification and characterization of a monoclonal antibody to the vaccinia virus E3 protein. Virus Res.130,269–274 (2007).
  Medline CASGoogle Scholar
• 77  Rubins KH, Hensley LE, Bell GW et al.: Comparative analysis of viral gene expression programs during poxvirus infection: a transcriptional map of the vaccinia and monkeypox genomes. PLoS ONE3,e2628 (2008).
  MedlineGoogle Scholar
• 78  Cao J, McNevin J, Holte S, Fink L, Corey L, McElrath MJ: Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific γ-interferon-secreting CD8⁺ T cells in primary HIV-1 infection. J. Virol.77,6867–6878 (2003).
  Medline CASGoogle Scholar
• 79  Draenert R, Altfeld M, Brander C et al.: Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses. J. Immunol. Methods275,19–29 (2003).
  Medline CASGoogle Scholar
• 80  Kaufmann DE, Bailey PM, Sidney J et al.: Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of GAG and NEF and the presence of broadly recognized peptides. J. Virol.78,4463–4477 (2004).
  Medline CASGoogle Scholar
• 81  Bui HH, Sidney J, Li W, Fusseder N, Sette A: Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines. BMC Bioinformatics8,361 (2007).
  MedlineGoogle Scholar
• 82  Peters B, Sidney J, Bourne P et al.: The immune epitope database and analysis resource: from vision to blueprint. PLoS Biol.3,e91 (2005).
  MedlineGoogle Scholar
• 83  Peters B, Sidney J, Bourne P et al.: The design and implementation of the immune epitope database and analysis resource. Immunogenetics57,326–336 (2005).
  Medline CASGoogle Scholar
• 84  Sathiamurthy M, Peters B, Bui HH et al.: An ontology for immune epitopes: application to the design of a broad scope database of immune reactivities. Immunome Res.1,2 (2005).
  MedlineGoogle Scholar
• 85  Sette A, Fleri W, Peters B, Sathiamurthy M, Bui HH, Wilson S: A roadmap for the immunomics of category A–C pathogens. Immunity22,155–161 (2005).
  Medline CASGoogle Scholar
• 86  Zhang Q, Wang P, Kim Y et al.: Immune epitope database analysis resource (IEDB-AR). Nucleic Acids Res.36,W513–W518 (2008).
  Medline CASGoogle Scholar
• 87  Bui HH, Peters B, Assarsson E, Mbawuike I, Sette A: Ab and T cell epitopes of influenza A virus, knowledge and opportunities. Proc. Natl Acad. Sci. USA104,246–251 (2007).
  Medline CASGoogle Scholar
• 88  Blythe MJ, Zhang Q, Vaughan K et al.: An analysis of the epitope knowledge related to mycobacteria. Immunome Res.3,10 (2007).
  MedlineGoogle Scholar
• 89  Ernst JD, Lewinsohn DM, Behar S et al.: Meeting report: NIH Workshop on the Tuberculosis Immune Epitope Database. Tuberculosis (Edinb.)88,366–370 (2008).
  MedlineGoogle Scholar
• 90  Zarebski LM, Vaughan K, Sidney J et al.: Analysis of epitope information related to Bacillus anthracis and Clostridium botulinum. Expert Rev. Vaccines7,55–74 (2008).
  Medline CASGoogle Scholar
• 91  Vaughan K, Blythe M, Greenbaum J et al.: Meta-analysis of immune epitope data for all plasmodia: overview and applications for malarial immunobiology and vaccine-related issues. Parasite Immunol.31,78–97 (2009).
  Medline CASGoogle Scholar
• 92  Chahroudi A, Garber DA, Reeves P, Liu L, Kalman D, Feinberg MB: Differences and similarities in viral life cycle progression and host cell physiology after infection of human dendritic cells with modified vaccinia virus Ankara and vaccinia virus. J. Virol.80,8469–8481 (2006).
  Medline CASGoogle Scholar
• 93  Engelmayer J, Larsson M, Subklewe M et al.: Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J. Immunol.163,6762–6768 (1999).
  Medline CASGoogle Scholar
• 94  Jenne L, Hauser C, Arrighi JF, Saurat JH, Hugin AW: Poxvirus as a vector to transduce human dendritic cells for immunotherapy: abortive infection but reduced APC function. Gene Ther.7,1575–1583 (2000).
  Medline CASGoogle Scholar
• 95  Liu L, Xu Z, Fuhlbrigge RC, Pena-Cruz V, Lieberman J, Kupper TS: Vaccinia virus induces strong immunoregulatory cytokine production in healthy human epidermal keratinocytes: a novel strategy for immune evasion. J. Virol.79,7363–7370 (2005).
  Medline CASGoogle Scholar
• 96  Coupar BE, Andrew ME, Both GW, Boyle DB: Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response. Eur. J. Immunol.16,1479–1487 (1986).
  Medline CASGoogle Scholar
• 97  Amanna IJ, Slifka MK, Crotty S: Immunity and immunological memory following smallpox vaccination. Immunol. Rev.211,320–337 (2006).▪▪ Excellent review describing the memory of responses following vaccinia infection and vaccination.
  Medline CASGoogle Scholar
• 98  Galmiche MC, Goenaga J, Wittek R, Rindisbacher L: Neutralizing and protective antibodies directed against vaccinia virus envelope antigens. Virology254,71–80 (1999).
  Medline CASGoogle Scholar
• 99  Mercer J, Traktman P: Investigation of structural and functional motifs within the vaccinia virus A14 phosphoprotein, an essential component of the virion membrane. J. Virol.77,8857–8871 (2003).
  Medline CASGoogle Scholar
• 100  Moutaftsi M, Salek-Ardakani S, Croft M et al.: Correlates of protection efficacy induced by vaccinia virus-specific CD8(⁺) T-cell epitopes in the murine intranasal challenge model. Eur. J. Immunol.39,717–722 (2009).
  Medline CASGoogle Scholar
• 101  Seet BT, Johnston JB, Brunetti CR et al.: Poxviruses and immune evasion. Annu. Rev. Immunol.21,377–423 (2003).▪▪ Excellent review describing the vast array of strategies for immune evasion developed and employed from vaccinia virus and other poxviruses.
  Medline CASGoogle Scholar
• 102  Li P, Wang N, Zhou D et al.: Disruption of MHC class II-restricted antigen presentation by vaccinia virus. J. Immunol.175,6481–6488 (2005).
  Medline CASGoogle Scholar
• 103  Kotturi MF, Peters B, Buendia-Laysa F Jr et al.: The CD8⁺ T-cell response to lymphocytic choriomeningitis virus involves the L antigen: uncovering new tricks for an old virus. J. Virol.81,4928–4940 (2007).
  Medline CASGoogle Scholar
• 104  Yewdell JW: Confronting complexity: real-world immunodominance in antiviral CD8⁺ T cell responses. Immunity25,533–543 (2006).▪▪ Excellent review/commentary on immunodominance issues.
  Medline CASGoogle Scholar
• 105  Ramirez MC, Sigal LJ: Macrophages and dendritic cells use the cytosolic pathway to rapidly cross-present antigen from live, vaccinia-infected cells. J. Immunol.169,6733–6742 (2002).
  Medline CASGoogle Scholar
• 106  Rock KL, Shen L: Cross-presentation: underlying mechanisms and role in immune surveillance. Immunol. Rev.207,166–183 (2005).
  Medline CASGoogle Scholar
• 107  Serna A, Ramirez MC, Soukhanova A, Sigal LJ: Cutting edge: efficient MHC class I cross-presentation during early vaccinia infection requires the transfer of proteasomal intermediates between antigen donor and presenting cells. J. Immunol.171,5668–5672 (2003).
  Medline CASGoogle Scholar
• 108  Shen X, Wong SB, Buck CB, Zhang J, Siliciano RF: Direct priming and cross-priming contribute differentially to the induction of CD8⁺ CTL following exposure to vaccinia virus via different routes. J. Immunol.169,4222–4229 (2002).
  Medline CASGoogle Scholar
• 109  Meyer H, Osterrieder N, Czerny CP: Identification of binding sites for neutralizing monoclonal antibodies on the 14-kDa fusion protein of orthopox viruses. Virology200,778–783 (1994).
  Medline CASGoogle Scholar
• 110  Mohamed M, Christen LA, Niles EG: Antibodies directed against an epitope in the N-terminal region of the H4L subunit of the vaccinia virus RNA polymerase inhibit both transcription initiation and transcription termination, in vitro. Virology299,142–153 (2002).
  Medline CASGoogle Scholar
• 111  Ichihashi Y, Oie M: Neutralizing epitope on penetration protein of vaccinia virus. Virology220,491–494 (1996).
  Medline CASGoogle Scholar
• 201  Poxvirus Bioinformatics Resource Center www.poxvirus.org
  Google Scholar
• 202  Immune Epitope Database and Analysis Resource. www.immuneepitope.org
  Google Scholar